N-Alkylamino Stilbene Compounds as Amyloid β Inhibitors for Alzheimer’s Disease Research

Alzheimer’s disease (AD) is an incurable neurodegenerative disorder that debilitates an overwhelming number of people in the aging population worldwide. The aggregated forms of the amyloid beta (Aβ) peptide play an important role in the onset of AD. Small molecules that can bind to Aβ are useful for...

Full description

Saved in:
Bibliographic Details
Main Authors: Citlali Gutiérrez, Liang Sun, Yiran Huang, Kai Gui, Karna Terpstra, Liviu M. Mirica
Format: Article
Language:English
Published: MDPI AG 2025-06-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/30/11/2471
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849722355721437184
author Citlali Gutiérrez
Liang Sun
Yiran Huang
Kai Gui
Karna Terpstra
Liviu M. Mirica
author_facet Citlali Gutiérrez
Liang Sun
Yiran Huang
Kai Gui
Karna Terpstra
Liviu M. Mirica
author_sort Citlali Gutiérrez
collection DOAJ
description Alzheimer’s disease (AD) is an incurable neurodegenerative disorder that debilitates an overwhelming number of people in the aging population worldwide. The aggregated forms of the amyloid beta (Aβ) peptide play an important role in the onset of AD. Small molecules that can bind to Aβ are useful for in vitro assays, in vivo imaging, and in therapeutic research. Herein, a series of compounds that can target Aβ aggregates and inhibit their formation were developed. The interaction of several compounds with the Aβ peptide was found to modulate the formation of aggregates. These N-alkylamino stilbene compounds offer selectivity toward Aβ species against other in situ proteins and have potential for aiding the development of soluble Aβ aggregate selective AD probes.
format Article
id doaj-art-db8dbdacd55d450b8f06436de3d5d38a
institution DOAJ
issn 1420-3049
language English
publishDate 2025-06-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj-art-db8dbdacd55d450b8f06436de3d5d38a2025-08-20T03:11:22ZengMDPI AGMolecules1420-30492025-06-013011247110.3390/molecules30112471N-Alkylamino Stilbene Compounds as Amyloid β Inhibitors for Alzheimer’s Disease ResearchCitlali Gutiérrez0Liang Sun1Yiran Huang2Kai Gui3Karna Terpstra4Liviu M. Mirica5Department of Chemistry, University of Illinois Urbana-Champaign, 600 S. Matthews Avenue, Urbana, IL 61801, USADepartment of Chemistry, University of Illinois Urbana-Champaign, 600 S. Matthews Avenue, Urbana, IL 61801, USADepartment of Chemistry, University of Illinois Urbana-Champaign, 600 S. Matthews Avenue, Urbana, IL 61801, USADepartment of Chemistry, University of Illinois Urbana-Champaign, 600 S. Matthews Avenue, Urbana, IL 61801, USADepartment of Chemistry, University of Illinois Urbana-Champaign, 600 S. Matthews Avenue, Urbana, IL 61801, USADepartment of Chemistry, University of Illinois Urbana-Champaign, 600 S. Matthews Avenue, Urbana, IL 61801, USAAlzheimer’s disease (AD) is an incurable neurodegenerative disorder that debilitates an overwhelming number of people in the aging population worldwide. The aggregated forms of the amyloid beta (Aβ) peptide play an important role in the onset of AD. Small molecules that can bind to Aβ are useful for in vitro assays, in vivo imaging, and in therapeutic research. Herein, a series of compounds that can target Aβ aggregates and inhibit their formation were developed. The interaction of several compounds with the Aβ peptide was found to modulate the formation of aggregates. These N-alkylamino stilbene compounds offer selectivity toward Aβ species against other in situ proteins and have potential for aiding the development of soluble Aβ aggregate selective AD probes.https://www.mdpi.com/1420-3049/30/11/2471Alzheimer’s diseasebeta-amyloidchemical toolsAβ probesprotein aggregation
spellingShingle Citlali Gutiérrez
Liang Sun
Yiran Huang
Kai Gui
Karna Terpstra
Liviu M. Mirica
N-Alkylamino Stilbene Compounds as Amyloid β Inhibitors for Alzheimer’s Disease Research
Molecules
Alzheimer’s disease
beta-amyloid
chemical tools
Aβ probes
protein aggregation
title N-Alkylamino Stilbene Compounds as Amyloid β Inhibitors for Alzheimer’s Disease Research
title_full N-Alkylamino Stilbene Compounds as Amyloid β Inhibitors for Alzheimer’s Disease Research
title_fullStr N-Alkylamino Stilbene Compounds as Amyloid β Inhibitors for Alzheimer’s Disease Research
title_full_unstemmed N-Alkylamino Stilbene Compounds as Amyloid β Inhibitors for Alzheimer’s Disease Research
title_short N-Alkylamino Stilbene Compounds as Amyloid β Inhibitors for Alzheimer’s Disease Research
title_sort n alkylamino stilbene compounds as amyloid β inhibitors for alzheimer s disease research
topic Alzheimer’s disease
beta-amyloid
chemical tools
Aβ probes
protein aggregation
url https://www.mdpi.com/1420-3049/30/11/2471
work_keys_str_mv AT citlaligutierrez nalkylaminostilbenecompoundsasamyloidbinhibitorsforalzheimersdiseaseresearch
AT liangsun nalkylaminostilbenecompoundsasamyloidbinhibitorsforalzheimersdiseaseresearch
AT yiranhuang nalkylaminostilbenecompoundsasamyloidbinhibitorsforalzheimersdiseaseresearch
AT kaigui nalkylaminostilbenecompoundsasamyloidbinhibitorsforalzheimersdiseaseresearch
AT karnaterpstra nalkylaminostilbenecompoundsasamyloidbinhibitorsforalzheimersdiseaseresearch
AT liviummirica nalkylaminostilbenecompoundsasamyloidbinhibitorsforalzheimersdiseaseresearch